Santhera Publishes Annual Report 2022
Pratteln, Switzerland, May 31, 2023 – Santhera Pharmaceuticals (SIX: SANN) announces the publication of its Annual Report 2022 with fully audited results for the year ended December 31, 2022.
Santhera’s Annual Report 2022 provides comprehensive and detailed information on the Company, its strategy, business, financial performance, governance and compensation in 2022, and confirms the preliminary unaudited 2022 annual results which were published on April 27, 2023. The Annual Report 2022 is available for download on the Company’s website at www.santhera.com/financial-reports.
Raxone® is a trademark of Santhera Pharmaceuticals.
Disclaimer / Forward-looking statements
# # #
Keynote Panel: The Continued Rise of AI: Embracing the Known and Unknown to Drive Business Results
MSPs and Compliance: Building a Security and Compliance Framework